From: Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study
Details
N = 13
Subcutaneous bleeding
3 (23.1)
Mouth hemorrhage
3 (23.1)a
Gastrointestinal hemorrhage
3 (23.1)b
Bleeding at the site of vascular access
2 (15.4)
Urinary hemorrhage
1 (7.7)a
Nasal hemorrhage
1 (7.7)
Alveolar hemorrhage